These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8382950

  • 1. Cytomegalovirus and coronary artery disease in heart transplant patients--accelerated low density lipoprotein and lipoprotein(a) modification as a proposed factor.
    Fay L.
    J Heart Lung Transplant; 1993; 12(1 Pt 1):155. PubMed ID: 8382950
    [No Abstract] [Full Text] [Related]

  • 2. Accelerated transplant coronary artery disease.
    Gao SZ, Hunt SA, Schroeder JS.
    Semin Thorac Cardiovasc Surg; 1990 Jul; 2(3):241-9. PubMed ID: 1964396
    [No Abstract] [Full Text] [Related]

  • 3. [Graft vascular disease. Its pathogenesis and diagnosis].
    Muñoz Aguilera R, García Robles JA, Palomo Alvarez J, Botas Rodríguez J.
    Rev Esp Cardiol; 1995 Jul; 48 Suppl 7():115-28. PubMed ID: 8775826
    [Abstract] [Full Text] [Related]

  • 4. Role of CMV in transplant coronary artery disease and survival after heart transplantation.
    Valantine HA.
    Transpl Infect Dis; 1999 Jul; 1 Suppl 1():25-30. PubMed ID: 11565583
    [Abstract] [Full Text] [Related]

  • 5. [Effects of aerobic and of strength physical exercises on HDL and LDL lipoproteins and lipoprotein(a)].
    Prado ES, Dantas EH.
    Arq Bras Cardiol; 2002 Oct; 79(4):429-33. PubMed ID: 12426654
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-10 correlates with oxidized low density lipoprotein in coronary culprit plaques.
    Nishihira K, Imamura T, Ishikawa T, Yamashita A, Shibata Y, Itabe H, Kitamura K, Asada Y.
    Thromb Res; 2009 Jul; 124(3):335-7. PubMed ID: 19272636
    [No Abstract] [Full Text] [Related]

  • 7. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.
    Park JW, Merz M, Braun P, Vermeltfoort M.
    J Heart Lung Transplant; 1996 Jun; 15(6):572-9. PubMed ID: 8803754
    [Abstract] [Full Text] [Related]

  • 8. Atherogenic lipoprotein subprofiling.
    Ellington AA, Kullo IJ.
    Adv Clin Chem; 2008 Jun; 46():295-317. PubMed ID: 19004193
    [Abstract] [Full Text] [Related]

  • 9. Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report.
    Min KW, Wickemeyer WJ, Chandran P, Shadur CA, Gervich D, Phillips SJ, Zeff RH, Song J.
    J Heart Transplant; 1987 Jun; 6(2):100-5. PubMed ID: 3040943
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat.
    Burman A, Jain K, Gulati R, Chopra V, Agarwal DP, Vasisht S.
    J Assoc Physicians India; 2004 Feb; 52():99-102. PubMed ID: 15656041
    [Abstract] [Full Text] [Related]

  • 11. Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia.
    Thiery J, Meiser B, Wenke K, Engelschalk C, Reichart B, Seidel D.
    Transplant Proc; 1995 Jun; 27(3):1950-3. PubMed ID: 7792847
    [No Abstract] [Full Text] [Related]

  • 12. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.
    Rosenson RS.
    Arch Intern Med; 1996 Jun 24; 156(12):1278-84. PubMed ID: 8651835
    [Abstract] [Full Text] [Related]

  • 13. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy.
    Jankowski J, Nofer JR, Tepel M, Griewel B, Schlüter H, Assmann G, Zidek W.
    Clin Sci (Lond); 1998 Oct 24; 95(4):489-95. PubMed ID: 9748425
    [Abstract] [Full Text] [Related]

  • 14. [The significance of cytomegalovirus infection in the period after a heart transplant].
    Manito N, Pérez JL, Roca J, Niubó J, Gausí C, Castells E.
    Rev Esp Cardiol; 1995 Oct 24; 48 Suppl 7():108-14. PubMed ID: 8775825
    [Abstract] [Full Text] [Related]

  • 15. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients.
    Albat B, Missov E, Serre I, Baldet P, Chaptal PA.
    Minerva Cardioangiol; 1995 Oct 24; 43(10):435-8. PubMed ID: 8819811
    [Abstract] [Full Text] [Related]

  • 16. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C, Greiber S, Krämer-Guth A, Heinloth A, Galle J.
    Kidney Int Suppl; 1997 Dec 24; 63():S102-6. PubMed ID: 9407434
    [Abstract] [Full Text] [Related]

  • 17. Lipoproteins in heart disease.
    Basile-Borgia A, Abel JH.
    Perfusion; 1996 Jul 24; 11(4):338-45. PubMed ID: 8884863
    [Abstract] [Full Text] [Related]

  • 18. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D, Sönmez H, Ekmekçi H, Ulutin T, Oztürk Z, Kökoğlu E, Bayram C, Soner A, Domaniç N.
    Clin Biochem; 2005 Jan 24; 38(1):92-6. PubMed ID: 15607324
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus infection and cardiac allograft vasculopathy in children.
    Webber SA.
    Circulation; 2007 Apr 03; 115(13):1701-2. PubMed ID: 17404170
    [No Abstract] [Full Text] [Related]

  • 20. Heart transplantation in Finland 1985-1995.
    Mattila S, Heikkilä L, Sipponen J, Verkkala K, Kyösola K, Mattila T, Järvinen A, Luosto R, Heikkinen L, Ketonen P, Salo J, Nemlander A, Mattila I, Nieminen MS.
    Ann Chir Gynaecol; 1997 Apr 03; 86(2):113-20. PubMed ID: 9366983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.